American Oncology Network and The Center for Cancer and Blood Disorders Welcome Dr. Garrett Diltz and Dr. Shreya Desai
American Oncology Network (NASDAQ:AONC) and The Center for Cancer and Blood Disorders (CCBD) have announced the addition of two board-certified medical oncologists to their physician team. Dr. Garrett Diltz and Dr. Shreya Desai will serve patients in Bethesda and Germantown, Maryland.
Dr. Diltz, a graduate of The Ohio State University College of Medicine, completed his fellowship at MedStar Georgetown University Hospital. Dr. Desai, fluent in Gujarati and Hindi, completed her fellowship at the Medical College of Georgia. Both physicians will join CCBD's comprehensive cancer care services, which include diagnostics, treatments, clinical trials, and survivorship programs.
American Oncology Network (NASDAQ:AONC) e The Center for Cancer and Blood Disorders (CCBD) hanno annunciato l'ingresso di due oncologi medici certificati nel loro team di medici. Il dott. Garrett Diltz e la dott.ssa Shreya Desai assisteranno i pazienti a Bethesda e Germantown, nel Maryland.
Il dott. Diltz, laureato presso il College of Medicine della Ohio State University, ha completato la sua fellowship presso il MedStar Georgetown University Hospital. La dott.ssa Desai, fluente in gujarati e hindi, ha completato la sua fellowship al Medical College of Georgia. Entrambi i medici si uniranno ai servizi completi di cura oncologica di CCBD, che includono diagnostica, trattamenti, studi clinici e programmi di sopravvivenza.
American Oncology Network (NASDAQ:AONC) y The Center for Cancer and Blood Disorders (CCBD) han anunciado la incorporación de dos oncólogos médicos certificados a su equipo de médicos. El Dr. Garrett Diltz y la Dra. Shreya Desai atenderán a pacientes en Bethesda y Germantown, Maryland.
El Dr. Diltz, egresado de The Ohio State University College of Medicine, completó su beca en MedStar Georgetown University Hospital. La Dra. Desai, que habla con fluidez gujarati e hindi, completó su beca en el Medical College of Georgia. Ambos médicos se unirán a los servicios integrales de atención oncológica de CCBD, que incluyen diagnóstico, tratamientos, ensayos clínicos y programas de supervivencia.
American Oncology Network (NASDAQ:AONC)와 The Center for Cancer and Blood Disorders (CCBD)가 두 명의 전문의 인증을 받은 종양내과 의사를 의료진에 추가했다고 발표했습니다. Garrett Diltz 박사와 Shreya Desai 박사는 메릴랜드주 베세스다와 저먼타운에서 환자들을 진료할 예정입니다.
Diltz 박사는 오하이오 주립대학교 의과대학을 졸업하고 MedStar Georgetown University Hospital에서 펠로우십을 마쳤습니다. Desai 박사는 구자라티어와 힌디어에 능통하며 Medical College of Georgia에서 펠로우십을 완료했습니다. 두 의사 모두 진단, 치료, 임상 시험 및 생존자 프로그램을 포함한 CCBD의 종합 암 치료 서비스에 합류할 것입니다.
American Oncology Network (NASDAQ:AONC) et le Center for Cancer and Blood Disorders (CCBD) ont annoncé l'intégration de deux oncologues médicaux certifiés à leur équipe de médecins. Le Dr Garrett Diltz et la Dre Shreya Desai prendront en charge des patients à Bethesda et Germantown, dans le Maryland.
Le Dr Diltz, diplômé du College of Medicine de l'Ohio State University, a effectué sa formation postdoctorale au MedStar Georgetown University Hospital. La Dre Desai, qui parle couramment le gujarati et l'hindi, a complété sa formation au Medical College of Georgia. Les deux médecins rejoindront les services complets de soins oncologiques du CCBD, comprenant le diagnostic, les traitements, les essais cliniques et les programmes de suivi des survivants.
American Oncology Network (NASDAQ:AONC) und das Center for Cancer and Blood Disorders (CCBD) haben die Aufnahme von zwei zertifizierten Fachärzten für medizinische Onkologie in ihr Ärzteteam bekannt gegeben. Dr. Garrett Diltz und Dr. Shreya Desai werden Patienten in Bethesda und Germantown, Maryland, betreuen.
Dr. Diltz, Absolvent des Ohio State University College of Medicine, absolvierte seine Facharztausbildung am MedStar Georgetown University Hospital. Dr. Desai, die fließend Gujarati und Hindi spricht, absolvierte ihre Facharztausbildung am Medical College of Georgia. Beide Ärzte werden sich den umfassenden Krebsbehandlungsdiensten von CCBD anschließen, die Diagnostik, Behandlungen, klinische Studien und Nachsorgeprogramme umfassen.
- None.
- None.
Board-certified medical oncologists join AON’s CCBD physician team
BETHESDA, Md., Aug. 07, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its partner practice, The Center for Cancer and Blood Disorders (CCBD), are pleased to welcome Board-certified medical oncologists Garrett Diltz, MD, and Shreya Desai, MD, to the care team. Both physicians will serve patients in Bethesda and Germantown, Maryland, alongside the practice’s existing team of experienced providers.
Dr. Diltz earned his medical degree from The Ohio State University College of Medicine, graduating summa cum laude and as a member of the Alpha Omega Alpha Honor Society. He completed his residency at Beth Israel Deaconess Medical Center/Harvard Medical School and his hematology-oncology fellowship at MedStar Georgetown University Hospital, where he was chief fellow.
“My goal is to provide personalized cancer care that supports the whole patient,” said Dr. Diltz. “I am excited to join the physician team at CCBD because they prioritize delivering the highest quality of care while building strong patient relationships, just as I do.”
Dr. Desai earned her medical degree from Ross University School of Medicine and completed her internal medicine residency at Rosalind Franklin University of Medicine and Science. She went on to complete a hematology-oncology fellowship at the Medical College of Georgia, where she served as chief fellow. She is fluent in Gujarati and Hindi.
“I am proud to join the physician team at The Center for Cancer and Blood Disorders and become a part of the American Oncology Network,” said Dr. Desai. “CCBD and AON share my commitment to high-quality, patient-focused care in a community setting, and the organizations’ reputation for excellence and compassion makes this the right fit for me.”
CCBD provides community-based oncology services to patients in Bethesda, Germantown, and Baltimore, Maryland. The practice offers comprehensive cancer care, including diagnostics, cutting edge treatments, clinical trials that offer innovative opportunities, survivorship programs and patient support – all delivered close to home to reduce travel burdens for patients and their families. CCBD clinics feature private exam rooms and on-site infusion suites designed for patient comfort and privacy during treatment.
“We are excited to have Dr. Desai and Dr. Diltz join our practice,” said Ralph Boccia, MD, FACP, Medical Director and managing partner. “Both doctors are dedicated to evidence-based, compassionate care, which aligns perfectly with our values and those of the other providers on our team. We are looking forward to benefiting from their expertise.”
“On behalf of AON, I am delighted to welcome these outstanding physicians to our network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Their experience and patient-centered approach will strengthen the level of care we offer in our Maryland communities and across the network.”
Dr. Desai and Dr. Diltz are now accepting new patients at CCBD’s Bethesda and Germantown locations. For more information about AON, visit AONcology.com. To learn more about The Center for Cancer and Blood Disorders, visit ccbdmd.com.
About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers’ innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About The Center for Cancer and Blood Disorders
Specialists in the diagnosis and treatment of blood disorders and cancer, The Center for Cancer and Blood Disorders has been serving patients in the communities and surrounding areas of Bethesda and Germantown, Maryland for more than 25 years. Their individualized approach to patient care includes chemotherapy, targeted therapy, immunotherapy and when appropriate, cutting-edge therapies on clinical trials. The practice regularly performs more than 300 clinical trials on new and developing diagnostic devices and techniques for cancer and diseases. Patients receive home delivery of oral cancer medications, in-house lab and pathology and on-site infusion therapy. The practice also offers comprehensive support with nutrition guidance and financial counseling. Learn more at ccbdmd.com.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/80961eff-6481-47ef-b73c-bf26cda97498
Media Contact: Karen Riley Sawyer American Oncology Network Karen.Sawyer@AONcology.com
FAQ
Who are the new oncologists joining American Oncology Network (AONC) and CCBD in 2025?
What are Dr. Garrett Diltz's qualifications and background?
What services does The Center for Cancer and Blood Disorders (CCBD) offer?
Where will the new AONC oncologists practice in Maryland?
What languages does Dr. Shreya Desai speak?
